Sources | Names Used |
---|---|
CTRPv2 | doxorubicin:navitoclax (2:1 mol/mol) |
PharmacoGx | doxorubicin:navitoclax (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | MED28 | CTRPv2 | pan-cancer | AAC | 0.18 | 1e-05 |
mRNA | KSR2 | CTRPv2 | pan-cancer | AAC | 0.14 | 1e-05 |
mRNA | DCAF16 | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-05 |
mRNA | PDE7A | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-05 |
mRNA | CTCF | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-05 |
mRNA | DLGAP3 | CTRPv2 | pan-cancer | AAC | 0.15 | 1e-05 |
mRNA | ADRM1 | CTRPv2 | pan-cancer | AAC | -0.14 | 1e-05 |
mRNA | CCDC74A | CTRPv2 | pan-cancer | AAC | 0.14 | 1e-05 |
mRNA | NDUFS8 | CTRPv2 | pan-cancer | AAC | -0.15 | 1e-05 |
mRNA | BAG3 | CTRPv2 | pan-cancer | AAC | -0.17 | 1e-05 |